Evidence map›Paper›PMID 34972200›Full record

ArticleBlood advances2022

Extent of intravital contraction of arterial and venous thrombi and pulmonary emboli.

Rafael R Khismatullin, Shahnoza Abdullayeva, Alina D Peshkova, Khetam Sounbuli, Natalia G Evtugina, Rustem I Litvinov, John W Weisel

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Deconstructing fibrin(ogen) structure.Journal of thrombosis and haemostasis : JTH · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Blood clot contraction: Mechanisms, pathophysiology, and disease.Research and practice in thrombosis and haemostasis · 2023
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rafael R KhismatullinDepartment of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA; and.ORCID 0000-0001-8597-811X
Shahnoza AbdullayevaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.ORCID 0000-0002-7647-2966
Alina D PeshkovaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.ORCID 0000-0002-8790-1818
Khetam SounbuliInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Natalia G EvtuginaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.ORCID 0000-0002-4950-3691
Rustem I LitvinovDepartment of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA; and.ORCID 0000-0003-0643-1496
John W WeiselDepartment of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA; and.ORCID 0000-0002-9628-257X
Kazan Federal University · RUUniversity of Pennsylvania · US

Funding

Subcellular Mechanisms pf Platelet ActivationP01HL040387 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BENNETT, JOEL S. · 1988 to 2018
$35.5M
Mechanisms of mechano-chemical rupture of blood clots and thrombiR01HL148227 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PUROHIT, PRASHANT KISHORE · 2020 to 2023
$2.5M
The Novel Mechanisms of Thrombosis Formation in Myeloproliferative DiseasesR01HL148014 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ABRAMS, CHARLES S. · 2020 to 2023
$2.5M
Scanning Electron MicroscopeS10OD018041 · OD · UNIVERSITY OF PENNSYLVANIA · PI WEISEL, JOHN W · 2014 to 2014
$382k
NHLBI NIH HHS P01 HL040387NHLBI NIH HHS R01 HL148014NHLBI NIH HHS R01 HL148227NIH HHS S10 OD018041
6 · The paper itself

Abstract

Blood clots and thrombi undergo platelet-driven contraction/retraction followed by structural rearrangements. We have established quantitative relationships between the composition of blood clots and extent of contraction to determine intravital contraction of thrombi and emboli based on their content. The composition of human blood clots and thrombi was quantified using histology and scanning electron microscopy. Contracting blood clots were segregated into the gradually shrinking outer layer that contains a fibrin-platelet mesh and the expanding inner portion with compacted red blood cells (RBCs). At 10% contraction, biconcave RBCs were partially compressed into polyhedral RBCs, which became dominant at 20% contraction and higher. The polyhedral/biconcave RBC ratio and the extent of contraction displayed an exponential relationship, which was used to determine the extent of intravital contraction of ex vivo thrombi, ranging from 30% to 50%. In venous thrombi, the extent of contraction decreased gradually from the older (head) to the younger (body, tail) parts. In pulmonary emboli, the extent of contraction was significantly lower than in the venous head but was similar to the body and tail, suggesting that the emboli originate from the younger portion(s) of venous thrombi. The extent of contraction in arterial cerebral thrombi was significantly higher than in the younger parts of venous thrombi (body, tail) and pulmonary emboli but was indistinguishable from the older part (head). A novel tool, named the "contraction ruler," has been developed to use the composition of ex vivo thrombi to assess the extent of their intravital contraction, which contributes to the pathophysiology of thromboembolism.

Indexed as

Pulmonary EmbolismThrombosisArteriesBlood PlateletsFibrinHumansFibrin

Identifiers

PMID34972200
PMCPMC8941457
OpenAlexW4205734402

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.